0      0

COVID's Impact on Pharma Facilities of the Future

Feb 1, 2022 8:45am ‐ Feb 1, 2022 10:15am

Credits: None available.


COVID's Impact on Pharma Facilities of the Future|The opening session will take a high-level look ahead at global pharmaceutical manufacturing and related regulatory systems. We will discuss how COVID has impacted our business and the applications of future manufacturing operations and the facilities required to adequately produce product that is safe, cost effective and meets the needs of the patients we serve. Key industry leaders will share their perspectives and their insights into how they see the industry changing as we move forward from COVID.

Session Leader(s):


  • Louis S. Schmukler, President, Global Product Development & Supply, Bristol-Myers Squibb
  • James Stephanou, Vice President Global Engineering Solutions, Merck
  • Matthew Hepburn, M.D., Senior Advisor To the Director, Pandemic Prevention, U.S. Office of Science and Technology Policy, Executive Office of the President


Credits: None available.

You must be logged in and own this session in order to post comments.